Artivion, Inc.
A maker of cardiac and vascular medical devices and preserved human tissues, Artivion helps surgeons treat aortic disease with products like the On-X mechanical heart valve, BioGlue surgical sealant, and aortic stent grafts, while its cryopreservation service banks donated heart valves and blood vessels. It began in 1984 as CryoLife, founded by Steven Anderson and Robert McNally as the first company to specialize in freezing human heart valves. In 2022 it renamed itself Artivion, a blend of "aorta," "innovation," and "vision."
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 13G/APassive | 6.5% | 3.18M | Aug 14, 2026 |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 13G/APassive | 6.5% | 3.18M | Aug 14, 2026 |
| FMR LLC | 13G/APassive | 4% | 1.96M | Aug 6, 2026 |
| Abigail P. Johnson | 13G/APassive | 4% | 1.96M | Aug 6, 2026 |
| The Vanguard Group | 13G/APassive | 0% | 0 | Mar 26, 2026 |
| Macquarie Group Limited | 13G/APassive | 0% | 0 | Feb 13, 2026 |
| Macquarie Management Holdings Inc | 13G/APassive | 0% | 0 | Feb 13, 2026 |
| Macquarie Investment Management Business Trust | 13G/APassive | 0% | 0 | Feb 13, 2026 |
| Perceptive Advisors LLC | 13G/APassive | 4.3% | 2.02M | Nov 14, 2025 |
| Joseph Edelman | 13G/APassive | 4.3% | 2.02M | Nov 14, 2025 |